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”Neurogenetics” studies the genetic basis of normal and abnor-
mal differentiation and function of the nervous system. The field
was pioneered by Seymour Benzer who investigated behavior
and neurodegeneration in Drosophila. His work has also in-
creased our knowledge of genetic aspects of neuronal (dys-)
function in other organisms including humans. Such knowledge
is a prerequisite for a better understanding of neurogenetic dis-
eases which are defined as “clinical disease(s) caused by a defect
in one ormore geneswhich affect the differentiation and function
of the neuroectoderm and its derivatives” [1]. Since the mid-
1980s of the last century, the advent of positional cloning tech-
niques has facilitated direct approaches to the elucidation of
neurogenetic disorders, temporarily overshadowing the rele-
vance of the study of model organisms.
The rapid identification of gene defects inmonogenic diseases
such as Huntington disease, ataxias, dystonias, and many others
prompted the inception of the journalNeurogenetics in 1997 as a
forum for the communication and discussion of findings in the
field. During its first 20 years of existence, the journal has mainly
focused on monogenic neurological disorders in humans and
occasionally reported relevant findings in other organisms.
Specifically, Neurogenetics has published experiments towards
a better understanding of pathological mechanisms caused by
mutations in single genes. During recent years, observations in
“complex” neurological disorders, i.e., diseases caused by alter-
ations in multiple genes and by environmental factors, have be-
come more prominently presented in the Journal.
At this junction, Ulrich Müller, a founding editor of the Journal,
is stepping down at the helm ofNeurogenetics andGeorgAuburger
follows him as an editor. In the coming years, we expect an increase
in publications on findings in the common “complex” neurological
disorders such as degenerative neural processes and epilepsies.
The study of the function of genes contributing to the com-
mon neuronal diseases will be expedited by the use of cell lines
(including induced pluripotent stem and neuronal cells) andmod-
el organisms such as Drosophila, and by the advent of high-
throughput sequencing techniques. Epigenetic phenomena such
as abnormal DNA methylation and histone acetylation are be-
coming increasingly recognized as important pathogenic factors
in neurological disorders as are the importance of RNA regula-
tion and toxicity. Furthermore, it is now becoming possible to
untangle the complexities of gene and brain function that result in
normal and abnormal behavior and contribute to intelligence and
emotions. The Journal is determined to cover these novel trends
and explicitly encourages submission of papers on the function
of genes implicated in common neurological diseases and traits.
We anticipate that these functional studies will point towards
causative therapies which shall be reported in Neurogenetics.
Given the many ongoing thrilling developments in the
field, we are looking forward to many more exciting years
of reporting groundbreaking discoveries in Neurogenetics.
Ulrich Müller, Giessen, Germany
Georg Auburger, Frankfurt, Germany
Manuel B. Graeber, Sydney, Australia
Louis J. Ptacek, San Francisco, CA, USA
November 2017
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Thank you, Professor Ulrich Müller, and Welcome,
Professor Georg Auburger!
The journal Neurogenetics was founded in 1997 by Professor
UlrichMüller and ProfessorManuel Graeber and Springer has
been fortunate to publish the journal since 1998. During the
first years of publication, the Journal quickly became a pre-
ferred venue for publishing findings that contribute to a better
understanding of the genetic basis of normal and abnormal
functions of the nervous system.
On behalf of Springer, I would like to warmly thank the
outgoing Founding Editor, Ulrich Müller, for his long-
standing commitment to Neurogenetics as well as for his en-
ergy and vision to found a new journal as soon as the new
research field had emerged. Over the past decades, Ulrich
Müller has been instrumental in advancing the field in
Germany as well as internationally.
And I would like to warmly welcome Professor Georg
Auburger to the team of Editors-in-Chief for Neurogenetics.
Over the past years, Georg Auburger has strongly supported
the journal as a referee and author. We at Springer are truly
honored to work with him and the whole editorial team. The
field of neurogenetics is constantly moving, especially with
the novel technologies and possibilities to study complex,
multi-gene diseases. There is little doubt that neurogenetics
will continue to flourish as a field for decades to come and
we look forward to a bright future forNeurogenetics.With this
inmind, the editors and publishers ofNeurogenetics offer their
best wishes to past, present and future authors, reviewers and
readers of the journal.
Andrea Pillmann, Executive Editor, Springer
Heidelberg, Germany
November 2017
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